Article · 27 Dec 2024
Research articlePublished 5 Apr 2021
Prescription pattern and cost variation analysis in type 2 diabetes mellitus patients at private outpatient department
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Diabetes is regarded as 21st century’s epidemic. To prevent complications, apart from life style modification pharmacotherapy is required to control blood sugar. Even though many oral antidiabetic drugs are available, satisfactory/target glycaemic control is not achieved. Cost of drug therapy is an important factor influencing compliance with treatment, particularly chronic diseases. So, need for periodic evaluation of prescription of diabetic patients. Aims and objective: To analyse pattern of antidiabetic drug prescriptions and percentage cost variation of prescribed antidiabetic drugs. Methods: This was a cross sectional observational study conducted among type 2 diabetes patients aged>12 yrs (either gender) at Out Patient Department (OPD) of private diabetes clinic during 2018-2019. Juvenile diabetes, gestational diabetes, indoor patients were excluded from the study. Patients were interviewed and details were filled up in case record form. Socio-demographic data, prescription pattern, percentage cost variation and cost ratio were analyzed. Result: Total 349 patients were enrolled with mean age 53 ± 12 years. Average no. of antidiabetic drugs per prescription was 3.34. Majority (96.56%) patients were prescribed at least one Fixed Dose Combination (FDC). Most common FDC was (97.99%) with biguanides and sulfonylureas. FDC with Metformin (500 mg) and glimepiride (2 mg) had maximum percentage cost variation (712.20) and very high cost ratio (8.12). Satisfactory glycemic levels were achieved in 58.45% patients. Conclusion: Polypharmacy, overuse of FDC’S with vast percentage cost variation and high cost ratio was observed. Need to pay attention towards diabetic education training, rational treatment approach and pricing control of medicine by regulatory agency
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Basic and Clinical Pharmacy.
Article · 27 Dec 2024
The Role of Binder Selection in Optimizing Tablet Strength and Dissolution
Article · 27 Dec 2024
Pharmacy-Based Interventions for Improving Maternal and Child Health
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Basic and Clinical Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Piparva Kiran G”
- BylineArticles whose byline prints “Singh Anil P”
- BylineArticles whose byline prints “Marki Karmur”